MicroVision (MVIS) Q4 2025 earnings review
Hard Pivot Costs $29M in Write-Downs as Revenue Evaporates
MicroVision is executing a dramatic reset. Despite management's claims of 'commercial momentum,' Q4 revenue decelerated to a negligible $0.2 million. The real story is the balance sheet: the company recognized $29.4 million in impairments and inventory write-downs in Q4 alone, driving Net Loss to an alarming $37.8 million. To survive, management is making desperate moves: acquiring Luminar and Scantinel assets, slashing the workforce by 20%, and issuing another $43 million in convertible notes. The transition from an R&D shop to a commercial enterprise is currently destroying capital at an accelerated rate.
🐂 Bull Case
Acquiring assets from struggling rivals (Luminar, Scantinel) for pennies on the dollar allows MicroVision to quickly diversify its product portfolio with ultra-long-range FMCW tech and secure immediate active customer engagements.
The planned 20% workforce reduction in 1H 2026 and facility consolidation to Orlando show management is finally matching its cost structure to market realities.
🐻 Bear Case
A year ago, management guided for $30-$50 million in revenue over 12-18 months. Total FY25 revenue came in at just $1.2 million. Credibility on commercial traction is severely damaged.
The massive $29.4 million in Q4 impairments suggests historical R&D and inventory were essentially worthless, directly contradicting past management claims of having 'the right products at the right time'.
⚖️ Verdict: 🔴🔴
Bearish. The company is surviving entirely on dilution and debt while burning capital. Until the acquired Luminar assets or new MOVIA shipments prove they can generate actual cash, the financial trajectory remains firmly negative.
Key Themes
Massive Impairments Contradict Positive Narrative
Management touted their 'careful preparation' and 'industry-leading' portfolio, but the financials tell a story of obsolescence. Q4 results included $29.4 million in non-cash charges: a $16.0M inventory write-down, $10.1M in intangible asset impairments, $2.2M in PP&E impairment, and $1.2M in lease impairments. Writing off $16 million of inventory—when total inventory entering the quarter was just $8.1 million—implies a near-total scrapping of legacy products. This represents a violent reversing of value for shareholders.
Acquisitions to Jumpstart Revenues
The organic growth strategy has failed, leading to a shift toward inorganic growth. MicroVision acquired assets from Scantinel Photonics (FMCW ultra-long-range lidar) and is closing on Luminar's lidar business assets in early 2026. This driver explicitly aims to 'accelerate immediate revenue opportunities' and bring active customer engagements, effectively buying the commercial traction they failed to generate internally.
The Disappearing Industrial Pipeline
In Q1 and Q4 of 2024, management confidently guided toward a $30-$50 million revenue pipeline in the industrial AMR/AGV vertical over 12-18 months. Fast forward to the end of 2025: Q4 revenue was just $223k and full-year revenue was $1.2 million. Growth is sharply decelerating, showing that long customer evaluation cycles and execution failures have completely derailed the core growth narrative.
Right-Sizing the Operating Structure
Facing relentless cash burn, management announced a 20% global workforce reduction slated for 1H 2026 and the consolidation of engineering and operations from Redmond to Orlando. If executed properly, this will be a primary driver of margin improvement and cash preservation.
Perpetual Debt and Dilution Dependency
To fund the new acquisitions and cover the ~$15M quarterly operating cash burn, MicroVision issued $43.0 million in senior secured convertible notes in February 2026. Part of this retired an existing note due in March 2026, pushing the maturity wall to March 2028. While it provides runway, it heavily dilutes existing shareholders and adds to the debt burden of a company generating almost zero cash.
Macro: Supply Chain Defensibility
While revenue is virtually absent, the company continues to leverage its European footprint (ZF manufacturing partnership in France and new German engineering teams) as a strategic hedge against Chinese tariffs and geopolitical supply chain risks. This remains a key selling point for Western OEMs.
Other KPIs
Stable but unsustainable. Cash burn remained stubbornly high (vs -$15.1M in 24Q4 and -$16.5M in 25Q3). FY25 total operating cash burn was $58.7M, an improvement from $68.5M in FY24, but still massive relative to the $1.2M in annual revenue.
GAAP gross loss was an astronomical $16.1M on $0.2M in revenue, entirely driven by the $16.0M in inventory write-downs. Even backing out the write-downs and amortization, Adjusted Gross Profit was a mere $125k.
Ended Q4 with $74.8M in cash and investments. In February, they added roughly $43M via new convertible notes (though some was an exchange for older debt). They also have $43.0M remaining on an ATM facility. The balance sheet is heavily leveraged toward future dilution.
Guidance
Accelerating cost cuts. Management explicitly guided to slashing global headcount by a fifth to streamline post-acquisition operating expenses and consolidate operations into the Orlando location.
Key Questions
Luminar Asset Revenue Contribution
You stated the Luminar asset acquisition will 'accelerate immediate revenue opportunities.' What is the exact quantified revenue backlog or run-rate you are acquiring, and when will it hit the P&L?
Anatomy of the $29.4M Impairment
Writing down $16 million in inventory and $10 million in intangibles implies a near-total wipeout of legacy product lines. Which specific products or capitalized assets were deemed worthless, and does this mark the end of the legacy MOVIA/MAVIN organic development?
The Missing Industrial Pipeline
Last year, you repeatedly guided to $30-$50 million in industrial demand over 12-18 months. With FY25 revenue at just $1.2 million, has that pipeline been officially lost to competitors, or is it merely delayed again?